


In the MedTech industry, ensuring patient safety requires early identification of risks. However, organizations often face challenges due to fragmented data across multiple systems, limiting visibility and preventing a unified view of product-level quality risks.
Traditional approaches rely heavily on manual data collection, where teams spend most of their time gathering information instead of focusing on proactive risk mitigation. Additionally, the absence of real-time insights results in delayed detection of issues, as risks are often identified only after appearing in periodic reports.
To address these challenges, the objective was to:
▸Establish a unified data layer to consolidate fragmented quality data
▸Enable proactive and real-time risk identification
▸Reduce manual effort and shift focus toward intelligent quality management
The Techylla team developed an AI-powered Intelligent Quality Ecosystem and implemented the following key initiatives:
▸Built a Comprehensive Data Layer (CDL) integrating 12+ enterprise data sources to create a single source of truth
▸Enabled LLM-powered conversational analytics (Quality-GPT) using RAG and Text-to-SQL, allowing users to access insights through natural language
▸Deployed Agentic AI ("Sentinel") for autonomous monitoring, reasoning, and action triggering based on real-time signals
▸Implemented RACI-driven automated alerts to identify stakeholders and ensure timely response and accountability
▸Integrated AI orchestration frameworks (LangChain & LangGraph) with secure AWS-based infrastructure for scalable and compliant operations
▸Established a closed-loop intelligence system enabling continuous monitoring, decision-making, and proactive quality management
▸Unified and instant data access
▸AI-driven proactive risk detection
▸Autonomous stakeholder alerts
▸Increased proactive focus

▸Unified and instant data access
▸AI-driven proactive risk detection
▸Autonomous stakeholder alerts
▸Increased proactive focus